Department of Chemistry, University of Kerala, Thiruvananthapuram, Kerala, 695581, India.
International Inter University Centre for Sensing and Imaging (IIUCSI), University of Kerala, Thiruvananthapuram, Kerala, 695581, India.
Mikrochim Acta. 2024 Oct 7;191(11):651. doi: 10.1007/s00604-024-06727-0.
A novel immunoassay platform is presented utilizing a cardiac troponin T antibody (Ab-cTnT) labelled with 5-carboxyfluorescein (5-FAM) integrated into a two-dimensional (2D) manganese dioxide nanosheet (MnO NS) matrix. This strategy enables a turn-on response towards cTnT antigen within a mere 10-min incubation period, boasting an impressive lower detection limit of 0.038 ng/mL. Crucially, our probe demonstrates exceptional selectivity amidst the presence of coexisting biomolecules and ions, ensuring precise detection of cTnT. Moreover, the developed platform showcases promising utility in sensing cTnT from spiked human serum samples, yielding satisfactory recovery percentages ranging from 82 to 105%. Additionally, we introduce and easy-to-use and cost-effective test strip for point-of-care detection of cTnT, further enhancing accessibility to critical cardiovascular diagnostics.
提出了一种新型免疫分析平台,该平台利用与 5-羧基荧光素(5-FAM)标记的心肌肌钙蛋白 T 抗体(Ab-cTnT)整合到二维(2D)二氧化锰纳米片(MnO NS)基质中。这种策略使得在仅 10 分钟的孵育时间内对 cTnT 抗原产生开启响应,具有令人印象深刻的 0.038ng/mL 的低检测限。至关重要的是,我们的探针在共存的生物分子和离子存在下表现出非凡的选择性,确保了 cTnT 的精确检测。此外,所开发的平台在检测加标人血清样本中的 cTnT 方面具有很有前景的实用性,回收率百分比从 82%到 105%不等,令人满意。此外,我们引入了一种易于使用且具有成本效益的测试条,用于即时检测 cTnT,进一步增强了对关键心血管诊断的可及性。